Phase 4 Ovarian Cancer Trial, Recruiting NCT06742710 Sponsor: Peking University Third Hospital Condition: Ovarian Cancer
Back to Ovarian Cancer

Phase 4 Ovarian Cancer Trial, Recruiting

NCT06742710
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman diagnosed with polycystic ovary syndrome (PCOS) using standard diagnostic guidelines called the Rotterdam criteria.
  • You are between 20 and 40 years old.
  • Your Body Mass Index (BMI) — a measure of weight relative to height — is between 25 and 35.
  • You have not taken any diabetes or weight-loss medications in the past 3 months (metformin is an exception and is allowed).
  • You have at least one frozen embryo stored at the research centre that can be used for transfer.
  • You are able to follow the birth control requirements set out by the study.

Who may not be able to join:

  • You have had a serious diabetes-related complication called diabetic ketoacidosis, or other urgent diabetes complications.
  • Your HbA1c (a blood test showing average blood sugar levels over time) was 9.0% or higher before joining the study.
  • You have taken any medications that affect appetite or how your body absorbs nutrients in the past 2 months (metformin is an exception and is allowed).
  • You have an uncontrolled thyroid condition, high blood pressure, or a whole-body immune system disease that could affect pregnancy or the baby's development.
  • A specific hormone level measured in your blood called 17-hydroxyprogesterone is above a certain level in the early part of your menstrual cycle (confirm with trial site).
  • You have serious heart, digestive, liver, or kidney disease, or certain infectious conditions such as chronic hepatitis B, active tuberculosis, or AIDS.
  • You have a mental health condition that requires medication to manage.
  • You have had three or more failed embryo implantations, two or more miscarriages, or a history of stillbirth, difficult delivery, birth defects, or serious pregnancy complications such as preeclampsia or HELLP syndrome.
  • Your partner has an uncontrolled metabolic, immune system, or inherited condition.
  • You have a medical reason why you should not take a type of medication called GLP-1 receptor agonists — for example, a personal or family history of a specific type of thyroid cancer, a history of inflamed gallbladder or pancreas, or a known allergy to this type of medication.
  • You are unable or unwilling to follow the study's required birth control methods.
  • You are unlikely to take your medication consistently or attend follow-up appointments as required.
  • You currently smoke, misuse alcohol, use recreational drugs, or have a substance abuse problem.
  • You have taken part in another clinical trial within the past 3 months.
  • The trial doctors have identified another reason they feel makes participation unsuitable for you (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 8601082265025

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Peking University Third Hospital
Registry
ClinicalTrials.gov
Start date
22 May 2025
Est. completion
30 May 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Live birth rate associated with single cycle frozen embryo transfer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov